Procalcitonin as a Biomarker and Risk Stratification Tool in COVID-19 Patients
O. M. Shah & N. Alaouabda · Journal of Advances in Medicine and Medical Research · 2022
Background: COVID-19 is a systemic disease with a highly variable clinical course, ranging from being asymptomatic to manifestations like bilateral interstitial pneumonia, and multi-organ failure. Aims & Objectives: To evaluate whether Procalcitonin can act as a biomarker for...
Open access
Research Article
10.9734/jammr/2022/v34i1731412